Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-21

Clinical Trial Update: Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial update on the safety and efficacy of dutogliptin in adults with type 2 diabetes mellitus on glimepiride with or without metformin; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dutogliptin (dutogliptin)
  • Glimepiride (glimepiride)
  • metformin (metformin)

Snippet

Sponsor: Forest Laboratories | Conditions: Diabetes Mellitus, Type II | Phase 3 | Status: TERMINATED